AstraZeneca approached Gilead about potential merger – Bloomberg News
LONDON (Reuters) – Britain’s AstraZeneca Plc (AZN.L) has approached U.S. rival Gilead Sciences Inc (GILD.O) about a possible merger that…
AstraZeneca scores twin drug approvals alongside vaccine progress
(Reuters) – Britain’s AstraZeneca has clinched expanded regulatory backing for two medications, including one for blockbuster cancer treatment Lynparza, in…
AstraZeneca’s Imfinzi gets speedy FDA review for small cell lung cancer
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New…
AstraZeneca succeeds in treating lupus in late-stage study
The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock…
Britain’s AstraZeneca to distribute Sun Pharma cancer drugs in China
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble BENGALURU…
FDA green lights AstraZeneca’s asthma drug Fasenra for self-administration
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, England, May 19, 2014. REUTERS/Phil Noble (Reuters) –…
Results of GSK and AstraZeneca trials may widen ovarian cancer drug use
BARCELONA (Reuters) – GlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a…
AstraZeneca plots China robot offensive to counter price cuts
WUXI, China/LONDON (Reuters) – With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients…
AstraZeneca sells rights for Seroquel to Luye Pharma for $538 million
LONDON (Reuters) – British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and…